Interestingly, preclinical and clinical data have reported the benefit of A1R activation in neurological conditions such as epilepsy [21], stroke [21], and chronic pain [73], as well as the benefit of A2AR hypofunction in stroke [21], chronic pain [74], Parkinson’s [75], and Alzheimer’s [76]. Here, ADORA2A is linked to stroke disorder.